NumFin

Idera Pharmaceuticals, Inc.

Símbolo: IDRA

NASDAQ

0.425

USD

Preço de mercado atual

  • -97.1145

    Rácio P/E

  • 7.8442

    Rácio PEG

  • 26.50M

    Capitalização da MRK

  • 0.00%

    Rendimento DIV

Idera Pharmaceuticals, Inc. (IDRA) Demonstrações financeiras

Download
AnualTrimestral
LinearLog
No gráfico, pode ver os números predefinidos em dinâmica para Idera Pharmaceuticals, Inc. (IDRA). A receita da empresa mostra a média de NaN M que é o crescimento de NaN %. O lucro bruto médio para todo o período é NaN M que é NaN %. O rácio médio da margem bruta é NaN %. O crescimento do rendimento líquido para o desempenho da empresa no último ano é NaN % que é igual a NaN % % em média para todo o historial da empresa.,

AnualTrimestral
10Y20Y30Y40Y

Balanço

Mergulhando na trajetória fiscal da Idera Pharmaceuticals, Inc., observamos um crescimento médio dos ativos. Essa taxa, curiosamente, está em , refletindo os altos e baixos da empresa. Quando comparado trimestre a trimestre, esse número se ajusta a . Uma retrospectiva do ano passado revela uma mudança total de ativos de NaN. O valor dos accionistas, representado pelo total do capital próprio, é avaliado em NaN na moeda de reporte. A variação anual deste aspeto é NaN%.

common:word.in-mln

USD
Growth
TTM2022202120202019201820172016201520142013201220112010200920082007200620052004200320022001200019991998199719961995

balance-sheet.row.cash-and-short-term-investments

65.441232.537.7
42.8
71.4
112.6
109
60.2
41.2
29.4
10.1
24.6
34.6
31.7
55.6
23.7
38.2
8.4
14.4
13.7
19.2
31.8
3.5
2.6
5.6
2.2
16.4
5.3

balance-sheet.row.short-term-investments

0004.5
2.8
0
0
28.3
33.6
21.3
3.1
0
0
17.6
6.3
10.4
11.2
13.6
7.4
9.4
6.1
14.6
10.9
2
0
0
0
3.8
0

balance-sheet.row.net-receivables

8.384.200
0
0
0
0
0
0
0
0
0
0
4.5
0.5
0.6
0.4
0.2
0.3
0.2
0.4
0.3
0.3
1.2
1.2
0.5
0
0

balance-sheet.row.inventory

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-current-assets

5.351.61.53.6
3.5
1.4
4
2
3.1
1.2
0.9
0.2
0.3
1
1
0.9
0.7
0.4
0.5
0.3
0.1
0.2
0.1
0.1
0.1
0.1
1
2.1
0.9

balance-sheet.row.total-current-assets

79.1617.93441.4
46.3
72.8
116.6
111
63.2
42.4
30.3
10.3
24.8
35.6
37.3
57
25
39
9
15
14
19.8
32.2
3.9
3.9
6.9
3.7
18.5
6.2

balance-sheet.row.property-plant-equipment-net

2.270.50.81
1.2
0.2
1.5
1.9
1.7
1.3
0.1
0.2
0.5
0.9
1.4
1.8
2
0.6
0.4
0.4
0.4
0.5
0.1
0.1
6.4
8.8
19.2
15.6
9.1

balance-sheet.row.goodwill

25.6611.100
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.intangible-assets

201.6771.600
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.goodwill-and-intangible-assets

227.3382.700
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.long-term-investments

0000
0
0
0
0
27
7.3
6.2
0
0
0
8.5
0
0
0
0
0
0
941.1
0
0
0
0
0
0
1.7

balance-sheet.row.tax-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-non-current-assets

0.8200.10.1
0.1
0
0.3
0.3
0.3
0.3
0.3
0.3
0.3
0.3
0.5
0.6
0.7
0.9
0.5
0
0
-940.1
0
6
1.6
0.9
12.1
7.4
2.6

balance-sheet.row.total-non-current-assets

230.4383.20.81
1.2
0.2
1.8
2.2
29
9
6.6
0.5
0.8
1.2
10.4
2.4
2.7
1.5
0.9
0.4
0.4
1.5
0.1
6.1
8
9.6
31.3
23
13.4

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

309.59101.134.942.4
47.5
73
118.4
113.2
92.3
51.4
36.9
10.8
25.6
36.9
47.6
59.4
27.7
40.5
10
15.4
14.4
21.2
32.3
10
11.9
16.5
35.1
41.5
19.6

balance-sheet.row.account-payables

15.525.20.60.3
0.5
1.1
1.3
0.6
1.2
2.5
0.9
1.1
1.2
1.8
1.2
1.3
1.2
1.2
0.5
0.4
0.7
0.8
0.5
1.1
1.6
2.4
8.1
4.1
2.1

balance-sheet.row.short-term-debt

0.920.20.20.2
0.2
0
0.2
0.3
0.3
0.1
0
0
0
0
0
0
0.3
0
0
0
1.3
0
3.4
6
6.1
6.1
7.9
1.3
0

balance-sheet.row.tax-payables

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.long-term-debt-total

1.420.30.50.8
0.9
0
0
0.2
0.5
0.7
0
0
0
0
0
0
0.9
5
5
0
0
1.3
1.3
9.4
7.8
1.8
53.3
9
1.1

Deferred Revenue Non Current

0000
0
0
0
0.2
1.3
0
0
0
0
0
0.1
12.2
9.9
15249.6
1229.5
523.7
651.2
363.4
26129.7
0
0
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

10.19---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

46.81164.16.5
53.9
7.9
8
7.4
4.3
4.5
3.5
3
4.9
1.8
0.9
1.2
1.7
0.9
1.3
1.3
1.1
0.8
-3097.6
1.1
2.5
4.1
11.9
4.3
3.9

balance-sheet.row.total-non-current-liabilities

142.9540.80.5126.5
4.1
0
0.6
0.5
1.9
1
0
0.1
7.5
0.2
0.3
12.4
10.9
20.3
6.3
0.8
0.7
1.7
27.4
9.4
7.8
1.8
53.3
9
1.2

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

2.330.60.80.9
1.1
0
0
0
0
0
0
0
0
0
0
0
0.1
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

206.2162.25.4133.6
58.7
9
10.7
9.9
8.7
8
4.4
4.2
13.6
3.8
14.5
37.2
20
28.3
10.3
2.6
3.9
3.8
32.3
17.5
18
14.3
81.1
18.7
7.2

balance-sheet.row.preferred-stock

55.234.300
0
0
0
0
0
0
11
9.6
5.9
0
0
0
0
0
0
0
0
0
6.4
0
0
0
0
0
0

balance-sheet.row.common-stock

0.1200.10
0
0
0.2
0.1
0.1
0.1
0.1
0
0
0
0
0
0
0
0.1
0.1
0.1
0
0
0
0
0
0
0
0

balance-sheet.row.retained-earnings

-3032.5-758.8-735.5-833.6
-720.9
-664.4
-604.5
-538.5
-500.1
-451.5
-412.9
-394.7
-375.4
-351.6
-333.7
-341.2
-342.7
-329.5
-313
-299.3
-283.9
-261.1
-273.9
-260.2
-253.2
-238.4
-218.7
-149.2
-102.3

balance-sheet.row.accumulated-other-comprehensive-income-loss

-0.02000
-0.8
-0.7
0
0
-0.1
0
0
-3.2
0
0
0
0
0
0
-0.1
0
0
0
-5.3
-5.3
-14.7
-13.8
-11.1
-6.6
-4.2

balance-sheet.row.other-total-stockholders-equity

3053.47736.4764.9742.3
710.5
729
712
641.7
583.7
494.9
434.3
394.8
381.5
384.7
366.8
363.4
350.4
341.7
312.6
312
294.4
278.6
272.7
257.9
261.8
254.5
183.7
178.6
118.9

balance-sheet.row.total-stockholders-equity

76.2711.829.5-91.2
-11.2
64
107.7
103.3
83.6
43.4
32.5
6.6
12
33.1
33.1
22.2
7.7
12.2
-0.3
12.8
10.5
17.4
0
-7.5
-6.1
2.2
-46
22.9
12.4

balance-sheet.row.total-liabilities-and-stockholders-equity

282.487434.942.4
47.5
73
118.4
113.2
92.3
51.4
36.9
10.8
25.6
36.9
47.6
59.4
27.7
40.5
10
15.4
14.4
21.2
32.3
10
11.9
16.5
35.1
41.5
19.6

balance-sheet.row.minority-interest

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-equity

76.2711.829.5-91.2
-11.2
64
107.7
103.3
83.6
43.4
32.5
6.6
12
33.1
33.1
22.2
7.7
12.2
-0.3
12.8
10.5
17.4
0
-7.5
-6.1
2.2
-46
22.9
12.4

balance-sheet.row.total-liabilities-and-total-equity

282.48---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

0004.5
2.8
0
0
28.3
60.6
28.6
9.3
0
0
17.6
14.7
10.4
11.2
13.6
7.4
9.4
6.1
15588.5
10.9
2
0
0
0
3.8
1.7

balance-sheet.row.total-debt

2.330.60.80.9
1.1
0
0.2
0.5
0.8
0.9
0
0
0
0
0
0
1.2
5
5
0
1.3
1.3
4.7
15.4
13.9
7.9
61.2
10.3
1.6

balance-sheet.row.net-debt

-63.1-11.5-31.8-32.3
-39
-71.4
-112.4
-80.2
-25.8
-19.1
-26.3
-10.1
-24.6
-17
-25.4
-45.1
-11.4
-19.6
4.1
-5
-6.3
-3.2
-16.2
13.8
11.3
2.2
58.9
-2.3
-3.7

Demonstração dos fluxos de caixa

O panorama financeiro da Idera Pharmaceuticals, Inc. registou uma alteração notável no fluxo de caixa livre durante o último período, apresentando uma mudança de NaN. A empresa aumentou recentemente o seu capital social através da emissão de NaN, marcando uma diferença de NaN em relação ao ano anterior. As actividades de investimento da empresa resultaram numa utilização líquida de tesouraria, no montante de NaN na moeda de relato. Trata-se de uma mudança de NaN em relação ao ano anterior. No mesmo período, A empresa registou NaN, NaN e NaN, que são significativos para compreender as estratégias de investimento e reembolso da empresa. As actividades de financiamento da empresa conduziram a uma utilização líquida de caixa de NaN, com uma diferença ano após ano de NaN. Além disso, a empresa atribuiu NaN para pagamento de dividendos aos seus accionistas. Ao mesmo tempo, envolveu-se noutras manobras financeiras, referidas como NaN, que também tiveram um impacto significativo no seu fluxo de caixa durante este período. Estes componentes, em conjunto, dão uma imagem abrangente da situação financeira da empresa e da abordagem estratégica relativamente à gestão do fluxo de caixa.

common:word.in-mln

USD
Growth
TTM20222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000199919981997199619951994

cash-flows.row.net-income

-41.05-23.498.1-112.7
-56.5
-59.9
-66
-38.4
-48.6
-38.6
-18.2
-19.2
-23.8
-18
7.5
1.5
-13.2
-16.5
-13.7
-12.7
-17.2
17
-5.3
-2.9
-10.5
-17.1
-69.5
-46.9
-34.5
-25.6

cash-flows.row.depreciation-and-amortization

0.01000.1
0.1
0.4
0.7
0.7
0.5
0.2
0.1
0.3
0.5
0.5
0.6
0.6
0.3
0.4
0.3
0.3
0.3
0.6
0.2
0.8
2.5
4.3
4.5
2.4
2
1.1

cash-flows.row.deferred-income-tax

-0.27-6.300
0
0
0
0
0
0
0
0
0
0
0
0
-1.6
-924.5
-99.7
-542.7
1297.4
1297.4
-1850.2
0
0
0
0
0
0
0

cash-flows.row.stock-based-compensation

02.22.53.6
3.8
5.7
10.7
6.8
5.4
4.3
1.4
2.1
2.8
3.7
3.1
0
1.6
924.5
99.7
542.7
-1297.4
-1297.4
1850.2
0
0
0
0
0
0
0

cash-flows.row.change-in-working-capital

-0.860.30.4-1.1
-3.3
1.3
-1
1.9
-1.2
2.5
-0.6
-2.4
0.8
-6.1
-26.9
18.4
-5.1
17.4
2.6
-0.3
0.2
-28.6
11.9
-6.5
-1.3
-1.2
12.3
2.7
0.2
2.3

cash-flows.row.account-receivables

2-2.300
0
0
0
0
0
0
0
0
0
4.5
0
0
-0.2
0
117.2
203.4
-131.4
-131.4
-243.4
0
0
0
0
0
0
0

cash-flows.row.inventory

0000
0
0
0
0
0
0
0
0
0
0.1
0
0
-0.3
0
-58.3
-356.4
-24
-59.6
734.4
0
0
0
0
0
0
0

cash-flows.row.account-payables

-2.742.5-1.8-1.6
-1.1
-0.9
1.7
2
-1.7
2.8
0.1
-2.4
0.2
1.4
0
0
0.9
-251.3
-61.3
139.6
144.9
144.9
-506.4
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

1.7-0.32.10.5
-2.2
2.2
-2.7
0
0.5
-0.3
-0.7
0.1
0.6
-12.2
-26.9
18.4
-5.5
268.8
5
13.2
10.7
17.6
27.3
-6.5
-1.3
-1.2
12.3
2.7
0.2
0

cash-flows.row.other-non-cash-items

9.522.7-125.676.3
11.3
0.6
0.2
0.7
0.9
0.3
0.2
-0.7
0.5
0.3
0
3
2.2
1.2
0.2
-0.6
2.4
0
6.3
0.8
0.7
-8.6
1.5
-0.4
-0.2
0.8

cash-flows.row.net-cash-provided-by-operating-activities

-29.78000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

0000
0
-0.1
-0.2
-0.4
-0.7
-1.1
0
0
0
-0.1
-0.1
-0.4
-1.6
-0.1
-0.2
-0.1
-0.1
-0.4
-0.1
0
0
-0.5
-7.5
-8.9
0
0

cash-flows.row.acquisitions-net

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-14080
403.6
-6396.4
0
0
0
0
0
0
0
0

cash-flows.row.purchases-of-investments

000-12.2
-44.5
0
0
-2.9
-63.1
-23.6
-9.3
-1
-1
-10.3
-14.8
-23
-50.5
-26.8
-19.9
-18.6
-17.7
-16
-13.7
-2
0
0
0
-7.5
0
0

cash-flows.row.sales-maturities-of-investments

004.510.5
42.1
0
28.3
34.7
30.4
4.1
0
18.6
18.6
7.2
10.4
23.6
53
20.6
21.9
15.2
29.4
10.9
20.2
0
0
0
3.8
0
0
0

cash-flows.row.other-investing-activites

5.485.500
0
0.3
0
0
0
0
0
0.1
0.1
0.1
0.1
0
0
-0.6
0
14080
-403.6
6396.4
0
11.6
0
6.2
0
0.4
-6.6
-5.1

cash-flows.row.net-cash-used-for-investing-activites

5.485.54.5-1.7
-2.4
0.2
28.1
31.4
-33.4
-20.6
-9.3
17.6
17.6
-3.1
-4.3
0.2
0.9
-6.9
1.8
-3.5
11.7
-5.5
6.5
9.6
0
5.7
-3.7
-16
-6.6
-5.1

cash-flows.row.debt-repayment

000-0.2
0
-0.2
-0.3
-0.3
-0.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-7.3
-1.6
-0.4
0
0

cash-flows.row.common-stock-issued

000.228.8
15.4
0
53.8
49
80.6
37.1
40.2
0
0
14.1
0
10
1.8
27.9
0.1
15.6
13.1
0.5
0.7
0.2
1.5
6.9
0
55.4
0
0

cash-flows.row.common-stock-repurchased

0000
0
0
0
0
0
0
0
0
0
0
0
-0.1
0
0
0
-5339.5
-5.3
0
0
0
0
0
0
0
41.9
19.8

cash-flows.row.dividends-paid

0000
0
0
0
0
0
-0.8
-1.1
-0.6
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-financing-activites

-1.58-1.519.30.1
0.1
10.4
5.7
2.2
2.5
9.3
3.5
6
9.1
0.1
0.3
-1.2
1.1
0
4.6
5338.2
0
-0.4
-1
-3
4.1
20.8
46
10.6
-0.8
1.4

cash-flows.row.net-cash-used-provided-by-financing-activities

-1.58-1.519.428.7
15.5
10.2
59.2
50.9
83
45.6
42.7
5.4
9.1
14.2
0.2
8.8
2.9
27.9
4.7
14.3
7.8
0.1
-0.3
-2.8
5.6
20.4
44.4
65.5
41.1
21.2

cash-flows.row.effect-of-forex-changes-on-cash

0000
0
0
0
0
0
0
0
-17.6
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.net-change-in-cash

-25.88-20.5-0.7-6.8
-31.4
-41.5
32
54.1
6.6
-6.3
16.2
-14.5
7.6
-8.5
-19.7
32.6
-12
23.6
-4
-2.6
5.1
-16.4
19.4
-1
-3
3.4
-10.4
7.3
1.9
-5.4

cash-flows.row.cash-at-end-of-period

65.441232.533.2
40
71.4
112.6
80.7
26.6
20
26.3
10.1
24.6
17
25.5
45.2
12.6
24.6
1
5
7.6
4.5
20.9
1.5
2.6
5.6
2.2
12.6
1.9
66.1

cash-flows.row.cash-at-beginning-of-period

91.3132.533.240
71.4
112.9
80.7
26.6
20
26.3
10.1
24.6
17
25.5
45.2
12.6
24.6
1
5
7.6
2.5
20.9
1.5
2.6
5.6
2.2
12.6
5.3
0
71.4

cash-flows.row.operating-cash-flow

-29.78-24.5-24.6-33.8
-44.5
-51.9
-55.3
-28.2
-43
-31.3
-17.1
-19.9
-19.2
-19.6
-15.6
23.6
-15.8
2.6
-10.5
-13.3
-14.4
-11
13.1
-7.8
-8.6
-22.7
-51.1
-42.1
-32.6
-21.4

cash-flows.row.capital-expenditure

0000
0
-0.1
-0.2
-0.4
-0.7
-1.1
0
0
0
-0.1
-0.1
-0.4
-1.6
-0.1
-0.2
-0.1
-0.1
-0.4
-0.1
0
0
-0.5
-7.5
-8.9
0
0

cash-flows.row.free-cash-flow

-29.78-24.5-24.6-33.8
-44.5
-52
-55.5
-28.6
-43.7
-32.4
-17.1
-19.9
-19.2
-19.6
-15.7
23.2
-17.4
2.5
-10.8
-13.4
-14.4
-11.4
13
-7.8
-8.6
-23.1
-58.7
-51
-32.6
-21.4

Linha de demonstração de resultados

A receita da Idera Pharmaceuticals, Inc. registou uma variação de NaN% em comparação com o período anterior. O lucro bruto de IDRA é reportado como NaN. As despesas operacionais da empresa são NaN, apresentando uma variação de NaN% em relação ao ano anterior. As despesas de depreciação e amortização são NaN, o que representa uma variação de NaN% em relação ao último período contabilístico. As despesas operacionais são reportadas como NaN, o que mostra uma variação anual de NaN%. As despesas de vendas e marketing são NaN, o que representa uma variação de NaN% em relação ao ano anterior. O EBITDA baseado nos números recentes é de NaN, representando um crescimento de NaN% em relação ao ano anterior. O rendimento operacional é NaN, que apresenta uma variação de NaN% em comparação com o ano anterior. A variação no rendimento líquido é de NaN%. O rendimento líquido do último ano foi de NaN.

common:word.in-mln

USD
Growth
TTM20222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000199919981997199619951994

income-statement-row.row.total-revenue

0000
1.4
0.7
0.9
16.2
0.2
0.1
0
0.1
0.1
16.1
34.5
26.4
8
2.4
2.5
0.9
0.9
30.3
0.8
0.3
7
4.5
3.9
4
1.4
1.2

income-statement-row.row.cost-of-revenue

5.67000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-0.8
-2.5
0
0
0
0
0

income-statement-row.row.gross-profit

-5.67000
1.4
0.7
0.9
16.2
0.2
0.1
0
0.1
0.1
16.1
34.5
26.4
8
2.4
2.5
0.9
0.9
30.3
0.8
1.1
9.5
4.5
3.9
4
1.4
1.2

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

15.4---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

14.73---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

28.558.31.30
0.2
4.4
0
0
0
0
0
0
0
0
0
0
0
0
99.7
0
542.7
6719.5
-4.1
0.8
2.5
0
0
0
0
0

income-statement-row.row.operating-expenses

51.5832.727.736.7
47.3
57.3
67.4
55
49.1
38.8
18.2
20
25.9
34.1
27.1
25.9
22.7
19
16.3
13.9
18.3
13.6
7.4
7.6
19.3
27.5
57.9
50.7
35.8
26.7

income-statement-row.row.cost-and-expenses

57.2532.727.736.7
47.3
57.3
67.4
55
49.1
38.8
18.2
20
25.9
34.1
27.1
25.9
22.7
19
16.3
13.9
18.3
13.6
7.4
6.8
16.8
27.5
57.9
50.7
35.8
26.7

income-statement-row.row.interest-income

0000.2
1.1
1.1
0.6
0.4
0.4
0
0
0
0
0
0
0
0
0
0
0
0
0
0.6
0.2
0
0
0
0
0
0

income-statement-row.row.interest-expense

0.020.200
0
0
0.1
0.1
0.1
0
0
0
0
0
0
0.1
0.1
0.4
0.3
0
0.1
0.2
1.3
2.2
0
0
0
0
-0.2
-0.1

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

-0.02-0.20-76
-10.4
1.1
0.5
0.4
0.3
0.1
-0.1
0.7
2.1
0
0.1
1
1.5
0
0.1
0.2
0.2
-0.2
0.5
0.1
0
0
-11
0
-0.2
-0.1

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

28.558.31.30
0.2
4.4
0
0
0
0
0
0
0
0
0
0
0
0
99.7
0
542.7
6719.5
-4.1
0.8
2.5
0
0
0
0
0

income-statement-row.row.total-operating-expenses

-0.02-0.20-76
-10.4
1.1
0.5
0.4
0.3
0.1
-0.1
0.7
2.1
0
0.1
1
1.5
0
0.1
0.2
0.2
-0.2
0.5
0.1
0
0
-11
0
-0.2
-0.1

income-statement-row.row.interest-expense

0.020.200
0
0
0.1
0.1
0.1
0
0
0
0
0
0
0.1
0.1
0.4
0.3
0
0.1
0.2
1.3
2.2
0
0
0
0
-0.2
-0.1

income-statement-row.row.depreciation-and-amortization

1.711.700.1
0.1
0.4
0.7
0.7
0.5
0.2
0.1
0.3
0.5
0.5
0.6
0.6
0.3
0.4
0.3
0.3
0.3
0.6
0.2
0.8
2.5
4.3
4.5
2.4
2
1.1

income-statement-row.row.ebitda-caps

-45.91---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

-47.62-29.598.1-36.7
-46.1
-61
-66.5
-38.8
-48.8
-38.8
-18.2
-19.9
-25.9
-18
7.4
0.5
-14.7
-16.6
-13.8
-12.9
-17.4
16.6
-6.6
-6.5
-9.8
-23
-64.9
-46.7
-34.4
-25.5

income-statement-row.row.income-before-tax

-47.64-29.798.1-112.7
-56.5
-59.9
-66
-38.4
-48.6
-38.6
-18.2
-19.2
-23.8
-18
7.5
1.5
-13.2
-16.5
-13.7
-12.7
-17.2
16.5
-6.1
-6.5
0
0
-75.9
0
-34.5
-25.6

income-statement-row.row.income-tax-expense

-6.59-6.30-76
-10.4
1.1
0.5
0.4
0.4
0.1
-0.1
0.7
2.1
0
0
0
1.7
0
0.4
0.2
0.3
-0.5
0.5
2.2
0
0
-11
0
-0.3
-0.1

income-statement-row.row.net-income

-41.05-23.498.1-112.7
-56.5
-59.9
-66
-38.4
-48.6
-38.6
-18.2
-19.2
-23.8
-18
7.5
1.5
-13.2
-16.5
-13.7
-12.7
-17.2
17
-5.3
-2.9
-10.5
-17.1
-69.5
-46.9
-34.5
-25.6
Acções semelhantes
Também pode interessar-lhe:
SRNE
Sorrento Therapeutics, Inc..
0.0145 USD
NASDAQ
MRVI
Maravai LifeSciences Holdings, Inc..
7.85 USD
NASDAQ
CMRA
Comera Life Sciences Holdings, Inc..
0.0361 USD
NASDAQ
T5O.DE
CytoTools AG.
0.488 EUR
XETRA
HBC.OL
Hofseth BioCare ASA.
2.06 NOK
OSL
PPBT
Purple Biotech Ltd..
0.67 USD
NASDAQ
SPHRF
Starpharma Holdings Limited.
0.0774 USD
PNK

Perguntas frequentes

O que é Idera Pharmaceuticals, Inc. (IDRA) total assets?

Idera Pharmaceuticals, Inc. (IDRA) o total de activos é 101107000.000.

Qual é a receita anual da empresa?

A receita anual é -49000.000.

Qual é a margem de lucro da empresa?

A margem de lucro da empresa é 58.878.

Qual é o fluxo de caixa livre da empresa?

O fluxo de caixa livre é -0.003.

Qual é a margem de lucro líquido da empresa?

A margem de lucro líquido é 665.265.

Qual é a receita total da empresa?

A receita total é 680.245.

O que é Idera Pharmaceuticals, Inc. (IDRA) lucro líquido (lucro líquido)?

O lucro líquido (rendimento líquido) é -23360000.000.

Qual é a dívida total da empresa?

A dívida total é 560000.000.

Qual é o número de despesas operacionais?

As despesas operacionais são 32680000.000.

Qual é o valor de caixa da empresa?

O dinheiro da empresa é 2118000.000.